CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Tiotropium bromide

Last Updated: May 23, 2018
Result type: Reports
Project Number: SR0412-000
Product Line: Reimbursement Review

Generic Name: Tiotropium bromide

Brand Name: Spiriva Respimat

Manufacturer: Boehringer Ingelheim (Canada) Ltd.

Therapeutic Area: Chronic obstructive pulmonary disease

Indications: Chronic Obstructive Pulmonary Disease (COPD)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 16, 2015

Recommendation Type: List with clinical criteria and/or conditions